Search
for
Sort by
Research 61–90 of 1000+
- Intermittent and Persistent Type 2 lupus: patient perspectives on two distinct patterns of Type 2 SLE symptoms
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Biotinidase deficiency – clinching the diagnosis rapidly can make all the difference!
- Pediatric Systemic Lupus Erythematosus
- Art of prevention: The importance of dermatologic care when using aromatase inhibitors
- Patient Recovery from COVID-19 Infections: Follow-Up of Hair, Nail, and Cutaneous Manifestations
- Case Report: Analytically Confirmed Severe Albenzadole Overdose Presenting with Alopecia and Pancytopenia
- Patient‐Level Adverse Event Patterns in a Single‐Institution Study of the Multi‐Kinase Inhibitor Sorafenib
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures
- The coudability sign of alopecia areata: the real story
- Gulf War Symptoms Remain Puzzling
- COVID-19: A catalyst for innovative hybrid teledermatology workflows to increase access and improve patient care at a large group practice
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Induction plus adjuvant chemotherapy, combined treatment with nimotuzumab, and intensity-modulated radiation therapy for N3 stage nasopharyngeal carcinoma
- THE FREQUENCY OF VISCERAL AND PHENOTYPIC MARKERS IN PATIENTS WITH THE COMBINATION OF UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE AND GASTROESOPHAGEAL REFLUX DISEASE
- Acquired Localized Hypertrichosis Following Pressure Garment and/or Silicone Therapy in Burn Patients
- Adverse Reaction to Cetuximab, an Epidermal Growth Factor Receptor Inhibitor.
- Fox-Fordyce Disease
- Are Pediatric GLP ‐1 Receptor Agonist Cutaneous Adverse Events Being Overlooked? Emerging Age‐Specific Patterns and Their Implications for Dermatologists
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- Manifestaciones dermatológicas asociadas a la gravedad de la infección por COVID-19. Estudio observacional transversal retrospectivo de 144 pacientes
- Efficacy assessment for low-level laser therapy in the treatment of androgenetic alopecia: a real-world study on 1383 patients
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- 127 Quality of life in patients with connective tissue diseases: results from the Lupus Extended Autoimmune Phenotype (LEAP) study
- Chemotherapy and Cutaneous Drug Reactions
- Serum sickness–like reaction in children: A retrospective review
- QUALITATIVE PATIENT INTERVIEW STUDY IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS TO ASSESS PATIENT PERCEPTION OF FATIGUE AND SKIN-RELATED SYMPTOMS